Ultracod

 Ultracod

Active Ingredients:

• Paracetamol – 300 mg

• Codeine or Codeine Phosphate – 10 mg, 8 mg, or 15 mg (depending on the country and manufacturer).

• Tablets: Round, white, with engraving.

• Capsules: Available in some countries as an alternative to tablets.

• Packaging: Blisters containing 10–20 tablets or capsules, 1–2 blisters in a cardboard box.

 The medication is used to relieve moderate to severe pain, including:

• Headache, toothache, muscle pain.

• Pain after surgeries and injuries.

• Fever and pain associated with colds and flu.

• Tablets and Capsules:

• Taken orally with a sufficient amount of water. Important: Do not chew to avoid altering the release rate of active ingredients.

• Adults and adolescents over 12 years old:

• Usual dosage: 1–2 tablets (or capsules) every 4–6 hours, depending on the severity of the pain.

• Maximum daily dose: 8 tablets (no more than 4000 mg of paracetamol and 240 mg of codeine per day!).

• Duration of use:

• Without medical supervision, no more than 3 days – prolonged use may lead to dependency (due to codeine) and liver toxicity (due to paracetamol).

• If pain persists for more than three days, consult a doctor.

• Special patient groups:

• Elderly patients, and those with liver or kidney diseases: Dosage reduction may be required as per the doctor’s recommendation.

• Contraindicated for children under 12 years due to the risk of respiratory depression.

• Additional recommendations:

• It is better to take the medication after meals to reduce the risk of stomach irritation.

• Avoid simultaneous use with alcohol and other medications containing paracetamol or codeine to prevent overdose.

• Hypersensitivity to paracetamol, codeine, or other components.

• Severe liver or kidney diseases.

• Respiratory failure.

• Children under 12 years of age.

• Pregnancy and breastfeeding.

• Risk of dependency with prolonged use of codeine.

• Use with caution in patients with bronchial asthma, epilepsy, or alcohol dependency.

• Do not exceed the recommended dose (risk of liver toxicity).

• Enhances the effects of sedatives, hypnotics, and antidepressants.

• Do not combine with alcohol (risk of liver toxicity).

• Use cautiously with CNS depressants.

• Contraindicated during pregnancy and breastfeeding (codeine passes into breast milk and may cause respiratory depression in the infant).

• May cause drowsiness, dizziness, and reduced concentration. Avoid driving or operating hazardous machinery.

• Nausea, vomiting, epigastric pain.

• Allergic reactions (skin rash, urticaria, itching, angioedema).

• Rarely: Thrombocytopenia, hemolytic anemia, methemoglobinemia, and liver or kidney dysfunction.

• Symptoms: CNS depression, nausea, vomiting, abdominal pain, respiratory failure.

• Treatment: Gastric lavage, activated charcoal, administration of acetylcysteine for paracetamol overdose.

• Paracetamol: Provides antipyretic and analgesic effects by blocking cyclooxygenase in the CNS.

• Codeine: An opioid analgesic that acts on opioid receptors, reducing pain and suppressing cough.

• Paracetamol: Maximum concentration reached within 30–60 minutes, excreted by the kidneys.

• Codeine: Metabolized in the liver, excreted by the kidneys.

• Analgesics-antipyretics in combination with opioids.

• Auxiliary components: Lactose, starch, magnesium stearate.

• Enhances the effects of sedatives and antidepressants.

• Avoid alcohol and CNS depressants.

• 3 years from the date of manufacture.

• Store at temperatures up to 25°C, protected from light and moisture.

• Tablets: 10–20 pieces in a blister, 1–2 blisters in a cardboard box.

• Do not dispose of in wastewater or household waste. Dispose of in accordance with local regulations.

• Officially registered in: USA, Canada, UK, France, Germany, Spain, Italy, Australia, New Zealand, South Africa, India, Brazil, Russia, China, Japan.

• Sandoz (Switzerland)

• Teva Pharmaceuticals (Israel)

• Mylan (USA)

• Sanofi (France)

• Aspen Pharmacare (South Africa)

• Actavis (USA, subsidiary of Teva Pharmaceuticals)

• In most countries (USA, EU, Russia) – prescription-only.

• In the UK and Australia, low doses may be available over the counter.

• Do not use after the expiration date.

• Dose adjustment is required for patients with liver and kidney diseases.

• Code: N02AJ06 (Paracetamol in combination with codeine).

• G43 Migraine

• J06 Acute upper respiratory infections of multiple and unspecified sites

• J11 Influenza, virus not identified

• M00-M25 Arthropathies

• M79.2 Neuralgia and neuritis, unspecified

• N94.6 Unspecified dysmenorrhea

• R50 Fever of unknown origin

• R51 Headache

• R52 Pain, not elsewhere classified

• R52.2 Other chronic pain